AKT1 and neoplasm: Additionally, formononetin downregulates estrogen receptor alpha (ERα)- and phosphorylated protein kinase B (p-Akt)-positive cells and protein levels, facilitating apoptosis and demonstrating cytotoxic effects on tumor cells.